Skip to content
Search
Search
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Menu
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Menu
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Michael Asbach
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Michael's Shared Resources
Study Uncovers Neural Network Vulnerability in Tardive Dyskinesia’s Orofacial Symptoms
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
TD Frequency and Antipsychotics
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Diagnostic and Treatment Basics in TD: A Review
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Impact of Treatment for a Patient With Tardive Dyskinesia
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Using “Extrapyramidal Symptoms” in Practice: Expert Perspective
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
An Overview of Extrapyramidal Side Effects
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
Load More
Share